^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

TNF inhibitor

Phase 2
Shandong First Medical University
Completed
Last update posted :
06/24/2024
Initiation :
11/11/2021
Primary completion :
06/16/2024
Completion :
06/16/2024
AFP
|
gemcitabine • albumin-bound paclitaxel • epirubicin • thalidomide
Phase N/A
Henan Cancer Hospital
Recruiting
Last update posted :
02/13/2024
Initiation :
07/11/2023
Primary completion :
03/01/2025
Completion :
05/01/2027
IL2
|
azacitidine • thalidomide
Phase 1
Washington University School of Medicine
Completed
Last update posted :
01/31/2024
Initiation :
10/26/2012
Primary completion :
12/27/2023
Completion :
12/27/2023
CD34
|
cyclophosphamide • thalidomide • cyclophosphamide intravenous
Phase 1/2
Hackensack Meridian Health
Completed
Last update posted :
01/02/2023
Initiation :
05/11/2010
Primary completion :
01/20/2016
Completion :
01/20/2016
BCL2 • CD34
|
bortezomib • thalidomide • melphalan • dexamethasone injection
Phase 1/2
Qilu Hospital of Shandong University
Not yet recruiting
Last update posted :
01/20/2022
Initiation :
03/10/2022
Primary completion :
03/10/2024
Completion :
12/10/2024
HER-2
|
HER-2 negative
|
oxaliplatin • thalidomide
Phase 3
National Cancer Institute (NCI)
Completed
Last update posted :
07/30/2019
Initiation :
02/01/2003
Primary completion :
01/01/2011
Completion :
01/01/2011
MUC16
|
tamoxifen • thalidomide • Soltamox (tamoxifen citrate)
Phase 2
Qilu Hospital of Shandong University
Unknown status
Last update posted :
06/05/2019
Initiation :
12/01/2016
Primary completion :
12/01/2020
Completion :
11/01/2021
EGFR • VEGFA
|
EGFR mutation
|
cisplatin • carboplatin • pemetrexed • thalidomide
Phase 4
Shenzhen Fifth People's Hospital
Unknown status
Last update posted :
12/19/2018
Initiation :
12/10/2018
Primary completion :
10/10/2020
Completion :
06/10/2021
IFNG • IL6 • TNFA • IL2 • IL10 • IL17A • IL21 • IL22
|
thalidomide • megestrol
Phase 2
Fujian Cancer Hospital
Unknown status
Last update posted :
11/14/2017
Initiation :
04/01/2017
Primary completion :
11/01/2019
Completion :
11/01/2020
EGFR
|
EGFR mutation • EGFR L858R • EGFR exon 19 deletion
|
gefitinib • thalidomide
Phase N/A
Eastern Cooperative Oncology Group
Completed
Last update posted :
05/17/2017
Initiation :
07/04/2008
Primary completion :
08/04/2008
Completion :
08/04/2008
CTSG
|
lenalidomide • thalidomide